The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
At present 18 per cent of the local pharmaceutical market is under government's price control
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian market
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
The lab will offer about 4,000 different tests ranging from basic to high-end molecular diagnostic tests
The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise
PPH is associated with almost 20 per cent of maternal mortality in India
The drug is also intended for the treatment of glioblastoma multiforme
Subscribe To Our Newsletter & Stay Updated
